Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 28 of 28 entries
View as:
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 02/29/12
Due: 02/28/13
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| An Intermediate Size Expanded Access Protocol of Elamipretide | NCT04689360 | Stealth BioTherapeutics Inc. | user2@example.com | None | - | - | - | - | - | 2025-07-14 |
| Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events | NCT01572909 | Stealth BioTherapeutics Inc. | user2@example.com | None | 2012-04-30 | 2015-02-28 | 2016-02-28 | - | - | 2025-07-14 |
| Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia | NCT01513200 | Stealth BioTherapeutics Inc. | user2@example.com | None | 2012-01-31 | 2012-02-29 | 2013-02-28 | - | - | 2025-07-14 |